Does Detectable Hbcrag or Pre-Genomic HBV RNA in Serum at Time of Nucleoside Analogue Therapy Withdrawal Predict Severe ALT Flare Outcome and the Need to Restart Therapy?
Journal article published in 2018 by
Ivana Carey,
Emily K. Butler,
Matthew Bruce,
Jeffrey Gersch,
Bo Wang,
Mary Kuhns,
Gavin Cloherty,
Geoffrey M. Dusheiko,
Kosh Agarwal 
